⬤


Education
Podcast About Our Clinical Trials
News About Our Clinical Trials
ACCRU Transformative Research
ACCRU Partners with Perthera
ACCRU News & Releases – June 8, 2022
ACCRU, a cancer research network operating within the Mayo Clinic, has officially partnered with Perthera, a leading precision oncology company, to bring innovative clinical trials to cancer patients throughout the country in the Target Panc Program. Perthera, with its Oncology Operating System™, will serve as the centralized “Molecular CRO” under the umbrella protocol. To read the full memo, click here: